Page last updated: 2024-08-24

simendan and Shock, Cardiogenic

simendan has been researched along with Shock, Cardiogenic in 78 studies

Research

Studies (78)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	35 (44.87)	29.6817
2010's	24 (30.77)	24.3611
2020's	19 (24.36)	2.80

Authors

Authors	Studies
Guo, B; Li, Y; Yang, B; Zhao, T	1
Kaddoura, R; Mohamed Ibrahim, MI; Omar, A	1
Au, SY; Fong, KM; Hau, M	2
Bertini, P; Brizzi, G; Costanzo, D; Esposito, A; Falcone, M; Guarracino, F; Landoni, G; Nocci, M; Paternoster, G; Romani, M	1
Hu, K; Mathew, R	1
Bruno, RR; Jung, C; Kelm, M	1
Belley-Côté, EP; Brodie, D; Combes, A; Di Santo, P; Fan, E; Fernando, SM; Hibbert, B; Lévy, B; Mathew, R; Rochwerg, B; Russo, JJ; Sadeghirad, B; Simard, T; Thiele, H; Tran, A; van Diepen, S	1
Bertini, P; Guarracino, F; Landoni, G; Marabotti, A; Paternoster, G	1
Belin, L; Bouglé, A; Charfeddine, A; Combes, A; De Rycke, Y; Duceau, B; Dureau, P; Hajage, D; Hariri, G; Lebreton, G; Massol, J; Simon-Tillaux, N; Tohme, J	1
Affronti, A; Bellani, G; Feri, M; Guarracino, F; Marini, M; Quacquarelli, A; Sangalli, F; Vitale, D; Volpi, F	1
Aissaoui, N; Benzadón, MN; Burgos, LM; Costabel, JP; Diez, M; Furmento, JF; Navia, D; Seoane, L; Vrancic, M	1
Achana, F; Armoiry, X; Fellahi, JL; Guilherme, E; Jacquet-Lagrèze, M; Pozzi, M	1
Chen, X; Lei, J; Liao, X; Qian, L; Zhang, S	1
Efremov, L; Frantz, S; Mikolajczyk, R; Schumann, J; Sedding, D; Tongers, J; Uhlig, K	1
Alonso-Fernandez-Gatta, M; Alzola, E; Barrio, A; Diego-Nieto, A; Gonzalez-Cebrian, M; Martin-Herrero, F; Merchan-Gomez, S; Sanchez, PL; Toranzo-Nieto, I	1
Alkhulaifi, A; Caliskan, K; Elsherbini, H; Ibrahim, MIM; Kaddoura, R; Lorusso, R; Omar, AS; Soliman, O	1
Alvarez, J; Bettex, D; Bouchez, S; Fruhwald, S; Girardis, M; Grossini, E; Guarracino, F; Heringlake, M; Herpain, A; Pollesello, P; Toller, W; Tritapepe, L	1
Abou-Arab, O; Besnier, E; Bouhemad, B; Cransac, A; Ellouze, O; Fischer, MO; Guinot, PG; Ksiazek, E; Mertes, PM; Moussa, M; Radhouani, M; Soudry Faure, A	1
Shang, G; Shang, Y; Song, D; Tang, M; Ti, Y; Wang, Z; Yang, X; Zhang, W; Zhang, Y; Zhong, M	1
Cao, H; Fang, M; Wang, Z	1
Frantz, S; Henrich, EC; Prondzinsky, R; Schumann, J; Strobl, H; Thiele, H; Unverzagt, S; Weiche, S; Werdan, K	1
Bettex, D; Jacky, A; Krüger, B; Paal, S; Rudiger, A; Seifert, B; Spahn, DR; Wilhelm, MJ	1
Anker, SD; Balligand, JL; Bauersachs, J; Brutsaert, D; Carrier, L; Chlopicki, S; Cleland, JG; de Boer, RA; de Keulenaer, G; Dietl, A; Eschenhagen, T; Fischmeister, R; Hamdani, N; Harjola, VP; Heinzel, FR; Heymans, S; Hilfiker-Kleiner, D; Holzmeister, J; Limongelli, G; Linke, WA; Lund, LH; Lyon, AR; Maack, C; Manstein, DJ; Masip, J; Mebazaa, A; Metra, M; Metzger, J; Mueller, C; Papp, Z; Pieske, B; Ponikowski, P; Ristić, A; Ruschitzka, F; Seferović, PM; Skouri, H; Tocchetti, CG; Yilmaz, MB; Zimmermann, WH	1
Bouchez, S; Girardis, M; Guarracino, F; Herpain, A; Knotzer, J; Levy, B; Liebregts, T; Pollesello, P; Ricksten, SE; Riha, H; Rudiger, A; Sangalli, F	1
Iotti, GA; Mojoli, F; Tavazzi, G; Via, G	1
Lyon, AR; Morley-Smith, AC; Omerovic, E	1
Brasseur, A; De Backer, D; Taccone, FS; Vincent, JL	1
Caliskan, K; Delnoij, TS; Donker, DW; Maessen, JG; Weerwind, PW; Wetzels, AE	1
Bleser, T; Görge, G; Weth, C	1
Buerke, M; Haerting, J; Hirsch, K; Prondzinsky, R; Thiele, H; Unverzagt, S; Wachsmuth, L; Werdan, K	1
Lanzillo, C; Mustilli, M; Romagnoli, E; Sette, A; Summaria, F	1
Arrigo, M; Brandão, JL; Feliot, E; Ferjani, M; Gayat, E; Hajjej, Z; Labbene, I; Mebazaa, A; Tavares, M; Tolppanen, H	1
Fuhrmann, JT; Rauwolf, T; Schmeisser, A; Schoen, SP; Schulze, MR; Strasser, RH; Weinbrenner, C; Wunderlich, C	1
Buerke, M; Prondzinsky, R	1
De Santis, V; Greco, C; Pietropaoli, P; Tritapepe, L; Vitale, D	1
Greif, M; Reithmann, C; Weis, M; Zwermann, L	1
Rijnders, BJ	1
Berthelsen, PG	1
Anastasiou-Nana, MI; Drakos, SG; Kanakakis, J; Katsaros, F; Lazaris, N; Malliaras, K; Nanas, JN; Ntalianis, AS; Tsagalou, EP	1
Carbucicchio, C; Grazi, M; Lauri, G; Marenzi, G	1
Eriksson, H; Salmenperä, M	1
Buerke, M; Carter, JM; Ebelt, H; Heinroth, K; Lemm, H; Prondzinsky, R; Russ, MA; Schlitt, A; Schmidt, H; Soeffker, G; Werdan, K; Winkler, M	1
Beute, J	1
Delle Karth, G; Heinz, G	1
Antonini, M; Cirasa, MT; Frustaci, A; Garotto, G; Stazi, GV	1
Yalta, K; Yilmaz, MB; Yontar, OC	1
Baldassarri, R; Guarracino, F; Landoni, G; Nobile, L; Stefani, M	1
Birhan Yilmaz, M; Erdem, A	1
Goldstein, DJ; Stern, DR; Sylvin, EA	1
Buerke, M; Lemm, H; Russ, M; Schlitt, A; Werdan, K	1
Albertsson, P; Boren, J; Grip, L; Hallgren, P; Holmberg, M; Matejka, G; Omerovic, E; Råmunddal, T	1
Buerke, U; Buerkem, B; Dietz, S; Krohe, K; Lemm, H; Raaz, U; Russ, M; Schlitt, A; Werdan, K	1
Liu, B; Liu, Y; Wei, LQ; Zhou, H	1
Berger, R; Buberl, A; Delle Karth, G; Geppert, A; Heinz, G; Huelsmann, M; Kopp, C; Neunteufl, T; Nikfardjam, M	1
Follath, F	1
Cavana, M; Fraticelli, A; Mebazaa, A; Pignataro, C	1
Boldt, J; Isgro, F; Kiessling, AH; Lang, J; Lehmann, A	1
Reuter, H; Schwinger, RH; Zobel, C	1
Domínguez-Rodríguez, A; Ferrer-Hita, JJ; García-González, MJ	1
Andersen, GØ; Bjørnerheim, R; Eritsland, J; Jonassen, A; Kløw, NE; Mangschau, A	1
Alhashemi, JA	1
Anis, L; Habib, H; Iheb, L; Moufida, H; Mustapha, F; Nedia, B	1
Abreu-González, P; Domínguez-Rodríguez, A; Ferrer-Hita, JJ; García-González, MJ; Muñoz, MB	1
Colucci, WS; De Luca, L; Gheorghiade, M; Massie, BM; Nieminen, MS	1
Hennersdorf, M; Müller, K; Peters, A; Strauer, BE; Zeus, T	1
Eriksson, HI; Hämmäinen, PJ; Petäjä, LM; Salmenperä, MT; Sipponen, JT; Suojaranta-Ylinen, RT	1
González-Chon, O; Guevara, M; Márquez, MF; Rivera, J; Romero, KA; Uruchurtu, E	1
Yasumura, Y	1
Abreu-González, P; Domínguez-Rodríguez, A; García-González, MJ; Samimi-Fard, S	2
D'Orio, V; Ghuysen, A; Harstein, G; Lambermont, B	1
Boldt, J; Isgro, F; Kiessling, AH; Lehmann, A; Thaler, E; Zeitler, C	1
Buerke, M; Buerke, U; Carter, JM; Christoph, A; Lemm, H; Prondzinsky, R; Reith, S; Russ, MA; Schlitt, A; Söffker, G; Swyter, M; Wegener, N; Werdan, K; Winkler, M	1
Buerke, M; Christoph, A; Janusch, M; Lemm, H; Prondzinsky, R; Reith, S; Russ, M; Schlitt, A; Werdan, K	1
Buerke, M; Russ, M; Werdan, K	1
Geppert, A; Smetana, P	1

Reviews

24 review(s) available for simendan and Shock, Cardiogenic

Article	Year
Short-term effects of levosimendan use for venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis. Perfusion, 2023, Volume: 38, Issue:2 Topics: Extracorporeal Membrane Oxygenation; Hospital Mortality; Humans; Intra-Aortic Balloon Pumping; Retrospective Studies; Shock, Cardiogenic; Simendan	2023
Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis. Minerva cardiology and angiology, 2023, Volume: 71, Issue:5 Topics: Extracorporeal Membrane Oxygenation; Humans; Shock, Cardiogenic; Simendan	2023
Inotrope and vasopressor use in cardiogenic shock: what, when and why? Current opinion in critical care, 2022, 08-01, Volume: 28, Issue:4 Topics: Cardiotonic Agents; Dobutamine; Humans; Shock, Cardiogenic; Simendan; Vasoconstrictor Agents	2022
[Pharmaceutical therapy of infarct-related cardiogenic shock]. Deutsche medizinische Wochenschrift (1946), 2022, Volume: 147, Issue:18 Topics: Humans; Myocardial Infarction; Pharmaceutical Preparations; Shock, Cardiogenic; Shock, Septic; Simendan	2022
Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2022, Volume: 69, Issue:12 Topics: Adult; Hemorrhage; Humans; Intra-Aortic Balloon Pumping; Myocardial Infarction; Network Meta-Analysis; Shock, Cardiogenic; Simendan; Treatment Outcome	2022
Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis. Perfusion, 2020, Volume: 35, Issue:6 Topics: Extracorporeal Membrane Oxygenation; Female; Humans; Male; Shock, Cardiogenic; Simendan; Survival Analysis; Vasodilator Agents	2020
Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock. Journal of healthcare engineering, 2020, Volume: 2020 Topics: Aged; Disease Progression; Dobutamine; Dopamine; Epinephrine; Female; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Network Meta-Analysis; Norepinephrine; Patient Safety; Recombinant Proteins; Shock, Cardiogenic; Simendan; Treatment Outcome	2020
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. The Cochrane database of systematic reviews, 2020, 11-05, Volume: 11 Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Dobutamine; Enoximone; Epinephrine; Humans; Hydrazones; Middle Aged; Myocardial Infarction; Nitric Oxide; Placebos; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents	2020
The Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management and Outcome: A Systematic Review and Meta-Analysis. Journal of cardiothoracic and vascular anesthesia, 2021, Volume: 35, Issue:8 Topics: Aged; Cardiac Surgical Procedures; Extracorporeal Membrane Oxygenation; Humans; Middle Aged; Randomized Controlled Trials as Topic; Shock; Shock, Cardiogenic; Simendan	2021
An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety. Expert review of cardiovascular therapy, 2021, Volume: 19, Issue:4 Topics: Adrenergic beta-Antagonists; Cardiac Surgical Procedures; Cardiotonic Agents; Critical Care; Dobutamine; Heart Failure; Hemodynamics; Humans; Shock, Cardiogenic; Simendan	2021
Effects of Levosimendan on Patients with Heart Failure Complicating Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2017, Volume: 17, Issue:6 Topics: Acute Coronary Syndrome; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan	2017
Levosimendan in patients with cardiogenic shock complicating myocardial infarction: A meta-analysis. Medicina intensiva, 2018, Volume: 42, Issue:7 Topics: Cardiotonic Agents; Clinical Trials as Topic; Glomerular Filtration Rate; Hemodynamics; Humans; Length of Stay; Myocardial Infarction; Organ Dysfunction Scores; Oxygen; Risk; Shock, Cardiogenic; Simendan; Treatment Outcome	2018
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. The Cochrane database of systematic reviews, 2018, 01-29, Volume: 1 Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Dobutamine; Enoximone; Humans; Hydrazones; Middle Aged; Myocardial Infarction; Nitric Oxide; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents	2018
Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper. Journal of cardiovascular pharmacology, 2019, Volume: 73, Issue:1 Topics: Animals; Cardio-Renal Syndrome; Cardiotonic Agents; Critical Care; Humans; Intensive Care Units; Recovery of Function; Risk Factors; Shock, Cardiogenic; Shock, Septic; Simendan; Treatment Outcome; Vasodilator Agents	2019
Takotsubo cardiomyopathy. British journal of hospital medicine (London, England : 2005), 2013, Volume: 74, Issue:2 Topics: Biomarkers; Cardiac Catheterization; Cardiovascular Agents; Echocardiography; Electrocardiography; Extracorporeal Membrane Oxygenation; Heart-Assist Devices; Hemodynamics; Humans; Hydrazones; Magnetic Resonance Imaging; Prognosis; Pyridazines; Shock, Cardiogenic; Simendan; Takotsubo Cardiomyopathy	2013
BET 1: Levosimendan in cardiogenic shock secondary to acute myocardial infarction. Emergency medicine journal : EMJ, 2013, Volume: 30, Issue:12 Topics: Acute Disease; Cardiotonic Agents; Evidence-Based Emergency Medicine; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Pyridazines; Shock, Cardiogenic; Simendan; Treatment Outcome	2013
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome. The Cochrane database of systematic reviews, 2014, Jan-02, Issue:1 Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Enoximone; Humans; Hydrazones; Myocardial Infarction; Nitric Oxide; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents	2014
Levosimendan in perioperative and critical care patients. Current opinion in anaesthesiology, 2009, Volume: 22, Issue:4 Topics: Animals; Cardiopulmonary Bypass; Critical Care; Heart; Humans; Hydrazones; Myocardial Contraction; Perioperative Care; Potassium Channels; Pyridazines; Sepsis; Shock, Cardiogenic; Simendan; Systole; Vasodilation	2009
Mechanical support for postcardiotomy cardiogenic shock: has progress been made? Journal of cardiac surgery, 2010, Volume: 25, Issue:4 Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Equipment Design; Extracorporeal Membrane Oxygenation; Heart-Assist Devices; Humans; Hydrazones; New York; Postoperative Complications; Pyridazines; Shock, Cardiogenic; Simendan; Time Factors	2010
[Therapeutic strategies in acute decompensated heart failure and cardiogenic shock]. Der Internist, 2010, Volume: 51, Issue:8 Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Combined Modality Therapy; Comorbidity; Critical Care; Cross-Sectional Studies; Diuretics; Emergency Service, Hospital; Heart Failure; Hospitalization; Humans; Hydrazones; Multicenter Studies as Topic; Myocardial Revascularization; Population Dynamics; Pyridazines; Risk Factors; Shock, Cardiogenic; Simendan; Vasodilator Agents	2010
The clinical experience with levosimendan in anesthesiology and in the intensive care unit. Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4 Suppl 2 Topics: Adrenergic beta-Antagonists; Anesthesia; Calcium Channels, L-Type; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Intensive Care Units; Myocardial Contraction; Pyridazines; Shock, Cardiogenic; Simendan; Systole; Ventricular Dysfunction, Left	2003
Evidence-based use of levosimendan in different clinical settings. European heart journal, 2006, Volume: 27, Issue:16 Topics: Administration, Oral; Adult; Arrhythmias, Cardiac; Cardiotonic Agents; Child; Heart Failure; Humans; Hydrazones; Intraoperative Care; Myocardial Ischemia; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan	2006
[Levosimendan for treatment of heart failure]. Nihon rinsho. Japanese journal of clinical medicine, 2007, May-28, Volume: 65 Suppl 5 Topics: Blood Pressure; Calcium; Cardiotonic Agents; Clinical Trials as Topic; Cytokines; Heart Failure; Heart Rate; Humans; Hydrazones; Inflammation Mediators; Natriuretic Peptide, Brain; Pyridazines; Shock, Cardiogenic; Simendan	2007
[New pharmacological treatment approaches to cardiogenic shock]. Der Internist, 2007, Volume: 48, Issue:12 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiotonic Agents; Catecholamines; Complement C5; Complement Inactivating Agents; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Myocardial Infarction; Myocardial Revascularization; Nitric Oxide Synthase; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Survival Rate; Vasopressins	2007

Trials

10 trial(s) available for simendan and Shock, Cardiogenic

Article	Year
Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data. Critical care (London, England), 2023, 02-07, Volume: 27, Issue:1 Topics: Cardiac Surgical Procedures; Extracorporeal Membrane Oxygenation; Hospital Mortality; Humans; Retrospective Studies; Shock, Cardiogenic; Simendan	2023
Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial. ESC heart failure, 2021, Volume: 8, Issue:4 Topics: Extracorporeal Membrane Oxygenation; Humans; Prospective Studies; Retrospective Studies; Shock, Cardiogenic; Simendan	2021
Comparison of Levosimendan and Milrinone for ECLS Weaning in Patients After Cardiac Surgery-A Retrospective Before-and-After Study. Journal of cardiothoracic and vascular anesthesia, 2018, Volume: 32, Issue:5 Topics: Aged; Cardiac Surgical Procedures; Cardiotonic Agents; Extracorporeal Membrane Oxygenation; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Male; Middle Aged; Milrinone; Postoperative Care; Retrospective Studies; Shock, Cardiogenic; Simendan; Switzerland	2018
Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Critical care medicine, 2008, Volume: 36, Issue:8 Topics: Aged; Cardiotonic Agents; Coronary Care Units; Enoximone; Female; Hemodynamics; Hospital Mortality; Humans; Hydrazones; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Phosphodiesterase Inhibitors; Pyridazines; Shock, Cardiogenic; Simendan	2008
Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta anaesthesiologica Scandinavica, 2003, Volume: 47, Issue:10 Topics: Aged; Blood Pressure; Cardiac Output; Cardiotonic Agents; Critical Illness; Dopamine; Drug Therapy, Combination; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Pyridazines; Shock, Cardiogenic; Simendan; Vasodilator Agents; Ventricular Function, Left	2003
Levosimendan in patients with low-output heart failure: lessons from the LIDO trial. Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4 Suppl 2 Topics: Adrenergic beta-Agonists; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Death, Sudden, Cardiac; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Morbidity; Myocardial Contraction; Pulmonary Wedge Pressure; Pyridazines; Risk Factors; Severity of Illness Index; Shock, Cardiogenic; Simendan; Stroke Volume; Survival Analysis; Time; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left	2003
Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics. European journal of heart failure, 2006, Volume: 8, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Humans; Hydrazones; Infusions, Intravenous; Middle Aged; Myocardial Infarction; Pyridazines; Shock, Cardiogenic; Simendan; Treatment Outcome	2006
Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty. International journal of cardiology, 2008, Jul-04, Volume: 127, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiotonic Agents; Dobutamine; Female; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Pyridazines; Shock, Cardiogenic; Simendan; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left	2008
Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty. International journal of cardiology, 2008, Aug-18, Volume: 128, Issue:2 Topics: Angioplasty, Balloon, Coronary; Cardiotonic Agents; Diastole; Dobutamine; Echocardiography, Doppler; Female; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan; Ventricular Function, Left	2008
Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Critical care medicine, 2007, Volume: 35, Issue:12 Topics: Angioplasty, Balloon, Coronary; Cardiotonic Agents; Catecholamines; Dobutamine; Female; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan	2007

Other Studies

44 other study(ies) available for simendan and Shock, Cardiogenic

Article	Year
Levosimendan for VA-ECMO weaning: the silver lining. ESC heart failure, 2022, Volume: 9, Issue:1 Topics: Extracorporeal Membrane Oxygenation; Humans; Shock, Cardiogenic; Simendan	2022
Levosimendan's effect on venoarterial extracorporeal membrane oxygenation weaning. The International journal of artificial organs, 2022, Volume: 45, Issue:6 Topics: Adult; Extracorporeal Membrane Oxygenation; Humans; Lactates; Retrospective Studies; Shock, Cardiogenic; Simendan	2022
Levosimendan's ability on veno-arterial extracorporeal membrane oxygenation weaning: Evidence says yes! The International journal of artificial organs, 2023, Volume: 46, Issue:4 Topics: Extracorporeal Membrane Oxygenation; Humans; Shock, Cardiogenic; Simendan	2023
Response to "Levosimendan's ability on veno-arterial extracorporeal membrane oxygenation weaning: Evidence says yes!" The International journal of artificial organs, 2023, Volume: 46, Issue:4 Topics: Extracorporeal Membrane Oxygenation; Humans; Shock, Cardiogenic; Simendan	2023
Levosimendan to facilitate weaning from cardiorespiratory support in critically ill patients: current evidence and future directions. Minerva anestesiologica, 2020, Volume: 86, Issue:6 Topics: Critical Illness; Extracorporeal Membrane Oxygenation; Heart Failure; Humans; Shock, Cardiogenic; Simendan	2020
Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis. Critical care (London, England), 2020, 07-16, Volume: 24, Issue:1 Topics: Adult; Aged; Cardiotonic Agents; Cohort Studies; Extracorporeal Membrane Oxygenation; Female; France; Humans; Male; Middle Aged; Propensity Score; Shock, Cardiogenic; Simendan; Ventilator Weaning	2020
Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: Impact on the success of weaning and survival. Artificial organs, 2021, Volume: 45, Issue:7 Topics: Cardiotonic Agents; Case-Control Studies; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock, Cardiogenic; Simendan	2021
Treatments targeting inotropy. European heart journal, 2019, 11-21, Volume: 40, Issue:44 Topics: Acute Disease; Animals; Antioxidants; Calcium; Cardiotonic Agents; Case-Control Studies; Catecholamines; Clinical Trials as Topic; Diastole; Dobutamine; Dogs; Energy Metabolism; Excitation Contraction Coupling; Heart Failure; Humans; Mitochondria; Models, Animal; Myocardial Contraction; Nitrogen Oxides; Oxidation-Reduction; Phosphodiesterase Inhibitors; Placebos; Receptors, Adrenergic; Sarcomeres; Shock, Cardiogenic; Simendan; Swine; Systole; Urea	2019
Does Levosimendan Have Room in Takotsubo Syndrome? JACC. Heart failure, 2019, Volume: 7, Issue:2 Topics: Heart Failure; Humans; Prognosis; Registries; Shock, Cardiogenic; Simendan; Takotsubo Cardiomyopathy	2019
Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock. Intensive care medicine, 2013, Volume: 39, Issue:8 Topics: Female; Humans; Hydrazones; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan; Subarachnoid Hemorrhage; Vasodilator Agents	2013
Peripheral venoarterial extracorporeal life support despite impending left ventricular thrombosis: a bridge to resolution. Journal of cardiothoracic and vascular anesthesia, 2013, Volume: 27, Issue:4 Topics: Advanced Cardiac Life Support; Anticoagulants; Biopsy; Enoximone; Extracorporeal Circulation; Heparin; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan; Vasodilator Agents; Venous Thrombosis; Ventricular Dysfunction, Left	2013
[Reverse takotsubo cardiomyopathy-a life-threatening disease. Successful resuscitation of a 31-year-old woman with cardiologic shock after a visit to the dentist]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2013, Volume: 108, Issue:8 Topics: Adult; Anesthesia, Dental; Anesthesia, Local; Apicoectomy; Combined Modality Therapy; Dental Anxiety; Electrocardiography; Female; Fluid Therapy; Heart Ventricles; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Phosphopyruvate Hydratase; Pyridazines; Radiography; Resuscitation; Shock, Cardiogenic; Simendan; Takotsubo Cardiomyopathy; Ventricular Fibrillation	2013
Early 'in-lab' use of levosimendan in patients with cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation. Therapeutic advances in cardiovascular disease, 2014, Volume: 8, Issue:1 Topics: Aged; Cardiotonic Agents; Counterpulsation; Humans; Hydrazones; Infusions, Intravenous; Intra-Aortic Balloon Pumping; Myocardial Infarction; Percutaneous Coronary Intervention; Pyridazines; Shock, Cardiogenic; Simendan; Time Factors; Treatment Outcome	2014
Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy. Anaesthesia, critical care & pain medicine, 2017, Volume: 36, Issue:1 Topics: Adult; Aged; Atrial Function, Right; Blood Pressure; Cardiac Output; Cardiomyopathies; Cardiotonic Agents; Catheterization; Echocardiography; Female; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Postpartum Period; Pulmonary Artery; Pyridazines; Retrospective Studies; Shock, Cardiogenic; Simendan; Stroke Volume	2017
Levosimendan in cardiogenic shock: better than enoximone! Critical care medicine, 2008, Volume: 36, Issue:8 Topics: Cardiotonic Agents; Enoximone; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan	2008
Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome. Annals of internal medicine, 2008, Sep-02, Volume: 149, Issue:5 Topics: Aged; Cardiotonic Agents; Female; Humans; Hydrazones; Pyridazines; Shock, Cardiogenic; Simendan; Takotsubo Cardiomyopathy	2008
Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction. Acute cardiac care, 2008, Volume: 10, Issue:3 Topics: Aged; Cardiac Output; Cardiotonic Agents; Combined Modality Therapy; Female; Hemodynamics; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Prospective Studies; Pyridazines; Shock, Cardiogenic; Simendan; Vasoconstrictor Agents; Ventricular Dysfunction, Left	2008
Evaluation of 30-day mortality of levosimendan versus enoximone. Critical care medicine, 2009, Volume: 37, Issue:3 Topics: Cardiotonic Agents; Enoximone; Humans; Hydrazones; Phosphodiesterase Inhibitors; Pyridazines; Shock, Cardiogenic; Simendan; Time Factors	2009
Levosimendan or enoximone in refractory cardiogenic shock? Critical care medicine, 2009, Volume: 37, Issue:3 Topics: Cardiotonic Agents; Enoximone; Humans; Hydrazones; Phosphodiesterase Inhibitors; Pyridazines; Shock, Cardiogenic; Simendan	2009
Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Acute cardiac care, 2009, Volume: 11, Issue:2 Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Phosphodiesterase Inhibitors; Pyridazines; Retrospective Studies; Shock, Cardiogenic; Simendan; Time Factors; Treatment Outcome; Vascular Resistance	2009
Use of levosimendan for treatment of cardiogenic shock associated with electrical storm. Annals of internal medicine, 2009, May-19, Volume: 150, Issue:10 Topics: Cardiotonic Agents; Defibrillators, Implantable; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan; Tachycardia, Ventricular; Ventricular Fibrillation	2009
Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan. Critical care medicine, 2009, Volume: 37, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Hemodynamics; Humans; Hydrazones; Middle Aged; Myocardial Infarction; Pyridazines; Shock, Cardiogenic; Simendan; Vasodilator Agents; Ventricular Function, Left; Ventricular Function, Right	2009
Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Critical care medicine, 2009, Volume: 37, Issue:9 Topics: Cardiotonic Agents; Enoximone; Humans; Hydrazones; Myocardial Infarction; Pyridazines; Shock, Cardiogenic; Simendan	2009
Do it right? Critical care medicine, 2009, Volume: 37, Issue:12 Topics: Humans; Hydrazones; Myocardial Infarction; Pyridazines; Shock, Cardiogenic; Simendan; Vasodilator Agents; Ventricular Function, Right	2009
Efficacy of levosimendan in Takotsubo-related cardiogenic shock. Acta anaesthesiologica Scandinavica, 2010, Volume: 54, Issue:1 Topics: Aged; Cardiotonic Agents; Female; Follow-Up Studies; Humans; Hydrazones; Pyridazines; Respiration, Artificial; Shock, Cardiogenic; Simendan; Takotsubo Cardiomyopathy	2010
Superiority of levosimendan over dobutamine in right ventricle failure. Critical care medicine, 2010, Volume: 38, Issue:1 Topics: Cardiotonic Agents; Critical Care; Critical Illness; Dobutamine; Female; Heart Function Tests; Humans; Hydrazones; Hypertension, Pulmonary; Intensive Care Units; Male; Myocardial Infarction; Prognosis; Pyridazines; Shock, Cardiogenic; Simendan; Survival Rate; Treatment Outcome; Vascular Resistance; Ventricular Dysfunction, Right	2010
Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock. British journal of anaesthesia, 2010, Volume: 104, Issue:3 Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Drug Therapy, Combination; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Propanolamines; Pyridazines; Shock, Cardiogenic; Simendan	2010
Importance of levosimendan on right ventricular function in patients with biventricular heart failure. Critical care medicine, 2010, Volume: 38, Issue:5 Topics: Hemodynamics; Humans; Hydrazones; Pyridazines; Shock, Cardiogenic; Simendan; Vasodilator Agents; Ventricular Function, Right	2010
Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction. Vascular health and risk management, 2010, Sep-07, Volume: 6 Topics: Age Factors; Aged; Atrial Fibrillation; Cardiotonic Agents; Chi-Square Distribution; Cohort Studies; Electrocardiography; Female; Heart Arrest; Humans; Hydrazones; Length of Stay; Male; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Pyridazines; Sex Factors; Shock, Cardiogenic; Simendan; Statistics, Nonparametric	2010
Levosimendan in the treatment of cardiogenic shock. Minerva cardioangiologica, 2010, Volume: 58, Issue:4 Topics: Anti-Arrhythmia Agents; Clinical Trials as Topic; Heart Failure; Humans; Hydrazones; Pyridazines; Shock, Cardiogenic; Simendan	2010
Continuous levosimendan infusion for refractory cardiogenic shock complicating severe acute dichlorvos poisoning. The American journal of the medical sciences, 2012, Volume: 344, Issue:2 Topics: Aged; Cardiotonic Agents; Dichlorvos; Humans; Hydrazones; Insecticides; Male; Pyridazines; Shock, Cardiogenic; Simendan	2012
Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series. Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:8 Topics: Adult; Aged; Cardiotonic Agents; Dopamine; Female; Humans; Hydrazones; Male; Middle Aged; Norepinephrine; Pyridazines; Shock, Cardiogenic; Simendan; Vascular Surgical Procedures; Vasoconstrictor Agents	2004
[Treatment of cardiogenic shock with the Ca2+ sensitizer levosimendan]. Medizinische Klinik (Munich, Germany : 1983), 2004, Dec-15, Volume: 99, Issue:12 Topics: Adult; Angioplasty, Balloon, Coronary; Cardiotonic Agents; Catheterization, Swan-Ganz; Coronary Stenosis; Drug Therapy, Combination; Hemodynamics; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Male; Myocardial Infarction; Pyridazines; Receptors, Calcium-Sensing; Shock, Cardiogenic; Simendan; Stents; Vasodilator Agents	2004
Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases. Journal of clinical pharmacology, 2005, Volume: 45, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Atrial Fibrillation; Calcium Channel Blockers; Cardiotonic Agents; Electrocardiography; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Middle Aged; Myocardial Infarction; Myocardial Stunning; Pericarditis; Pyridazines; Respiration, Artificial; Shock, Cardiogenic; Simendan; Ventricular Dysfunction, Left	2005
[Cardiogenic shock-- new therapeutic strategies]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2005, May-19, Volume: 125, Issue:10 Topics: Cardiotonic Agents; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Pyridazines; Shock, Cardiogenic; Simendan	2005
Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists. British journal of anaesthesia, 2005, Volume: 95, Issue:5 Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Drug Therapy, Combination; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Propanolamines; Pyridazines; Shock, Cardiogenic; Simendan	2005
[Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction]. La Tunisie medicale, 2005, Volume: 83, Issue:10 Topics: Cardiotonic Agents; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Pyridazines; Shock, Cardiogenic; Simendan; Stroke Volume; Treatment Outcome	2005
[Therapy of acute decompensated heart failure with levosimendan]. Medizinische Klinik (Munich, Germany : 1983), 2006, Mar-22, Volume: 101 Suppl 1 Topics: Adult; Aged; Calcium Channel Agonists; Cardiotonic Agents; Conscious Sedation; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Norepinephrine; Pyridazines; Shock, Cardiogenic; Simendan	2006
Levosimendan reversing low output syndrome after heart transplantation. The Annals of thoracic surgery, 2006, Volume: 82, Issue:4 Topics: Cardiotonic Agents; Heart Transplantation; Humans; Hydrazones; Male; Middle Aged; Myocardial Reperfusion Injury; Pyridazines; Recovery of Function; Shock, Cardiogenic; Simendan; Time Factors; Treatment Outcome	2006
Severe stunned myocardium after lightning strike. Critical care medicine, 2007, Volume: 35, Issue:1 Topics: Adult; Cardiotonic Agents; Causality; Critical Care; Disease Progression; Echocardiography; Electrocardiography; Epilepsy, Tonic-Clonic; Exercise Test; Female; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Lightning Injuries; Monitoring, Physiologic; Myocardial Stunning; Pyridazines; Radiopharmaceuticals; Recovery of Function; Severity of Illness Index; Shock, Cardiogenic; Simendan; Technetium Tc 99m Sestamibi; Thallium; Ventricular Dysfunction, Left	2007
Levosimendan: right for the right ventricle? Critical care medicine, 2007, Volume: 35, Issue:8 Topics: Acute Disease; Animals; Cardiotonic Agents; Hydrazones; Pulmonary Embolism; Pyridazines; Shock, Cardiogenic; Simendan; Swine; Ventricular Dysfunction, Right	2007
Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization. European journal of anaesthesiology, 2008, Volume: 25, Issue:3 Topics: Acute Disease; Aged; Anti-Arrhythmia Agents; Blood Pressure; Case-Control Studies; Catecholamines; Cohort Studies; Coronary Artery Bypass; Emergencies; Female; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Intra-Aortic Balloon Pumping; Length of Stay; Male; Middle Aged; Monitoring, Intraoperative; Myocardial Ischemia; Myocardial Revascularization; Pyridazines; Respiration, Artificial; Retrospective Studies; Shock, Cardiogenic; Simendan; Survival Rate; Vascular Resistance	2008
Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction. Acute cardiac care, 2008, Volume: 10, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiotonic Agents; Female; Hemodynamics; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Male; Myocardial Contraction; Myocardial Infarction; Pulmonary Artery; Pyridazines; Shock, Cardiogenic; Simendan; Time Factors; Vascular Resistance	2008
Levosimendan in cardiogenic shock: the magic drug for every patient? Critical care medicine, 2007, Volume: 35, Issue:12 Topics: Cardiotonic Agents; Hemodynamics; Humans; Hydrazones; Myocardial Revascularization; Pyridazines; Shock, Cardiogenic; Simendan	2007